T1	intervention 22 31	nebivolol
T2	condition 40 76	anthracycline-induced cardiomyopathy
T3	No-of-participants 317 319	45
T4	intervention-participants 420 422	27
T5	control 427 434	placebo
T6	control-participants 438 440	18
T7	outcome-Measure 443 473	Echocardiographic measurements
T8	outcome-Measure 478 538	N-terminal pro-brain natriuretic peptide (NT-pro-BNP) levels
T9	outcome 632 659	echocardiographic variables
T10	outcome 733 773	end-systolic and end-diastolic diameters
T11	outcome 1060 1064	LVEF
